Skip to main content
SoftOx Solutions AS logo

SoftOx Solutions AS — Investor Relations & Filings

Ticker · SOFTX ISIN · NO0010811961 LEI · 549300AETMWJS91G4A50 OL Manufacturing
Open in API
Filings indexed 574 across all filing types
Latest filing 2020-03-31 Report Publication Anno…
Country NO Norway
Listing OL SOFTX

About SoftOx Solutions AS

https://soft-ox.com/

SoftOx Solutions AS is a clinical-stage pharmaceutical company that has developed a patented, non-toxic antimicrobial technology. The technology is based on a stabilized formulation of hypochlorous acid (HOCl), an endogenous molecule used by the human immune system to combat pathogens. It is designed to be highly effective against a broad spectrum of bacteria, viruses, and fungi, and to eradicate and prevent biofilm infections. A key feature of the technology is that its mode of action does not induce antimicrobial resistance (AMR). The company's development pipeline focuses on significant health challenges, with a lead candidate, SoftOx Inhalation Solution (SIS), for treating airway infections, as well as other applications in wound care and disinfection.

Recent filings

Filing Released Lang Actions
SoftOx Solutions AS - 4th. quarter report 2019
Report Publication Announcement Classification · 98% confidence The document explicitly states it is the 'SoftOx Solutions AS - 4th. quarter report 2019' and mentions that the report is 'Attached'. Given the very short length (262 characters) and the nature of the text announcing the availability of the full report rather than containing the comprehensive financial data itself, this fits the definition of a Report Publication Announcement (RPA) according to the 'MENU VS MEAL' rule. It is announcing the publication of the quarterly report.
2020-03-31 English
SoftOx Solutions AS - 4th. quarter report 2019
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the 4th quarter of 2019, titled 'Report 4th quarter of 2019'. It includes detailed operational reviews, financial highlights, a profit and loss statement, and a formal declaration signed by the board of directors. Since it covers a period shorter than a full fiscal year and contains substantive financial data and analysis, it is classified as an Interim/Quarterly Report. Q4 2019
2020-03-31 English
SoftOx Solutions AS - 4th. quarter report 2019
Report Publication Announcement Classification · 98% confidence The document text explicitly states "SoftOx Solutions AS - 4th. quarter report 2019" and then immediately says "Attached is SoftOx Solutions AS - 4th. quarter report 2019". The document length is extremely short (158 characters). According to the 'MENU VS MEAL' rule, a short announcement stating a report is attached or published should be classified as a Report Publication Announcement (RPA), rather than the full report itself (which would likely be classified as IR if it were comprehensive).
2020-03-31 English
OSLO BØRS - MATCHING HALT ENDS
Regulatory Filings Classification · 95% confidence The document text is extremely short (205 characters) and announces the end of a 'MATCHING HALT' on the Oslo Børs, referencing a previous announcement and detailing the re-opening auction schedule. This is a brief, time-sensitive market announcement regarding trading status, not a comprehensive financial report (like 10-K or IR) or a standard corporate action announcement (like DIV or CAP). Since it is a general regulatory/exchange announcement that doesn't fit the specific categories like DVA, DLST, or DIRS, the most appropriate fallback category is Regulatory Filings (RNS).
2020-03-30 English
OSLO BØRS - MATCHING HALT
Regulatory Filings Classification · 95% confidence The document text is extremely short (143 characters) and announces a 'MATCHING HALT' imposed by 'OSLO BØRS' in anticipation of an announcement. This is a general regulatory action or market notice, not a specific financial report (like 10-K, ER, or IR). Since it is a brief, non-specific regulatory announcement that doesn't fit the other defined categories (like DVA, DIV, DIRS, etc.), the most appropriate fallback category is Regulatory Filings (RNS).
2020-03-30 English
Innovation Norway supports SoftOx with a loan of NOK 6 million to increase production capacity of the company's fully virucidal hand disinfectant
Capital/Financing Update Classification · 98% confidence The document text is very short (952 characters) and announces a specific financial event: receiving a loan of NOK 6 million from Innovation Norway to increase production capacity. This relates directly to company financing and capital structure changes, specifically debt funding. This aligns best with the 'Capital/Financing Update' category (CAP). It is not a full report, an earnings release, or a management discussion, but a specific announcement about funding.
2020-03-25 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.